204 related articles for article (PubMed ID: 24558023)
1. Effort myocardial ischemia during chemotherapy with 5-fluorouracil: an underestimated risk.
Lestuzzi C; Vaccher E; Talamini R; Lleshi A; Meneguzzo N; Viel E; Scalone S; Tartuferi L; Buonadonna A; Ejiofor L; Schmoll HJ
Ann Oncol; 2014 May; 25(5):1059-64. PubMed ID: 24558023
[TBL] [Abstract][Full Text] [Related]
2. Fluoropyrimidine-associated cardiotoxicity: revisited.
Saif MW; Shah MM; Shah AR
Expert Opin Drug Saf; 2009 Mar; 8(2):191-202. PubMed ID: 19309247
[TBL] [Abstract][Full Text] [Related]
3. Failure of oral nitrate and calcium channel blocker therapy to prevent 5-fluorouracil-related myocardial ischemia: a case report.
Akpek G; Hartshorn KL
Cancer Chemother Pharmacol; 1999; 43(2):157-61. PubMed ID: 9923822
[TBL] [Abstract][Full Text] [Related]
4. Cardiotoxicity following different doses and schedules of 5-fluorouracil administration for malignancy -- a survey of 427 patients.
Tsavaris N; Kosmas C; Vadiaka M; Efremidis M; Zinelis A; Beldecos D; Sakelariou D; Koufos C; Stamatelos G
Med Sci Monit; 2002 Jun; 8(6):PI51-7. PubMed ID: 12070449
[TBL] [Abstract][Full Text] [Related]
5. A Case of 5-Fluorouracil-Induced Cardiac Arrest.
Ray JC; Cho P; Dragon M; Graham CG
J Emerg Med; 2016 Jan; 50(1):e1-6. PubMed ID: 26482827
[TBL] [Abstract][Full Text] [Related]
6. Myocardial Ischemia Induced by 5-Fluorouracil: A Prospective Electrocardiographic and Cardiac Biomarker Study.
Dyhl-Polk A; Schou M; Vistisen KK; Sillesen AS; Serup-Hansen E; Faber J; Klausen TW; Bojesen SE; Vaage-Nilsen M; Nielsen DL
Oncologist; 2021 Mar; 26(3):e403-e413. PubMed ID: 32959474
[TBL] [Abstract][Full Text] [Related]
7. Continuous ambulatory ECG monitoring during fluorouracil therapy: a prospective study.
Rezkalla S; Kloner RA; Ensley J; al-Sarraf M; Revels S; Olivenstein A; Bhasin S; Kerpel-Fronious S; Turi ZG
J Clin Oncol; 1989 Apr; 7(4):509-14. PubMed ID: 2466960
[TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity of 5-flourouracil: two case reports.
Tutkun A; Inanli S; Caymaz O; Ayanoğlu E; Duman D
Auris Nasus Larynx; 2001 Apr; 28(2):193-6. PubMed ID: 11240331
[TBL] [Abstract][Full Text] [Related]
9. Incidence and risk markers of 5-fluorouracil and capecitabine cardiotoxicity in patients with colorectal cancer.
Dyhl-Polk A; Vaage-Nilsen M; Schou M; Vistisen KK; Lund CM; Kümler T; Appel JM; Nielsen DL
Acta Oncol; 2020 Apr; 59(4):475-483. PubMed ID: 31931649
[No Abstract] [Full Text] [Related]
10. [Coronary artery stenting in the treatment of 5-fluorouracil-induced unstable angina].
Grześk G; Orzałkiewicz Z; Polak G; Przybył R; Nartowicz E; Szadujkis-Szadurski L; Grabczewska Z
Przegl Lek; 2003; 60(1):46-8. PubMed ID: 12884648
[TBL] [Abstract][Full Text] [Related]
11. [Myocardial necrosis and cardiogenic shock with normal coronaries: cardiotoxicity due to 5-FU or catecholamine cardiomyopathy].
Rodríguez Roldán JM; Lara Alvarez MA; López Martínez J; Díaz Abad R; Caballero Campo M; Del Nogal Sáez F
Med Intensiva; 2006 Apr; 30(3):123-4. PubMed ID: 16729482
[No Abstract] [Full Text] [Related]
12. 5-FU-induced cardiac toxicity--an underestimated problem in radiooncology?
Steger F; Hautmann MG; Kölbl O
Radiat Oncol; 2012 Dec; 7():212. PubMed ID: 23241239
[TBL] [Abstract][Full Text] [Related]
13. Fluorouracil induces myocardial ischemia with increases of plasma brain natriuretic peptide and lactic acid but without dysfunction of left ventricle.
Jensen SA; Hasbak P; Mortensen J; Sørensen JB
J Clin Oncol; 2010 Dec; 28(36):5280-6. PubMed ID: 21079148
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic options in patients with 5-fluorouracil-associated cardiotoxicity.
Cianci G; Morelli MF; Cannita K; Morese R; Ricevuto E; Di Rocco ZC; Porzio G; Lanfiuti Baldi P; Ficorella C
Br J Cancer; 2003 May; 88(10):1507-9. PubMed ID: 12771913
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic 5-fluorouracil-induced sinus bradycardia.
Lee AD; McKay MJ
Intern Med J; 2011 Jul; 41(7):566-70. PubMed ID: 21762335
[TBL] [Abstract][Full Text] [Related]
16. [5-fluorouracil: cause of a fatal myocardial infarction in combined radiochemotherapy?].
Maurer U; Härle M; Jungius KP
Strahlenther Onkol; 1996 May; 172(5):257-9. PubMed ID: 8633257
[TBL] [Abstract][Full Text] [Related]
17. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
[TBL] [Abstract][Full Text] [Related]
18. Cardiotoxicity of 5-fluorouracil.
Alter P; Herzum M; Soufi M; Schaefer JR; Maisch B
Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):1-5. PubMed ID: 16529545
[TBL] [Abstract][Full Text] [Related]
19. Usefulness of Heart-Type Fatty Acid-Binding Protein and Myocardial Performance Index for Early Detection of 5-Fluorouracil Cardiotoxicity.
Turan T; Agac MT; Aykan AÇ; Kul S; Akyüz AR; Gökdeniz T; Gül İ; Cengiz E; Boyacı F; Erkan H; Akdemir R; Celik S
Angiology; 2017 Jan; 68(1):52-58. PubMed ID: 26980771
[TBL] [Abstract][Full Text] [Related]
20. Severe ventricular dysrhythmias and silent ischemia during infusion of the antimetabolite 5-fluorouracil and cis-platin.
Hrovatin E; Viel E; Lestuzzi C; Tartuferi L; Zardo F; Brieda M; Dametto E; Piazza R; Antonini-Canterin F; Vaccher E; Meneguzzo N; Nicolosi GL
J Cardiovasc Med (Hagerstown); 2006 Aug; 7(8):637-40. PubMed ID: 16858245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]